{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:13:15Z","timestamp":1777111995035,"version":"3.51.4"},"reference-count":100,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100009109","name":"Pharmaceuticals Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary biliary cholangitis (PBC) is a rare progressive immune\u2010mediated liver disease that, if not adequately treated, may culminate in end\u2010stage disease and need for transplantation. According to current guidelines, PBC is diagnosed in the presence of antimitochondrial antibodies (AMA) or specific antinuclear antibodies, and of a cholestatic biochemical profile, while biopsy is recommended only in selected cases. All patients receive ursodeoxycholic acid (UDCA) in first line; the only registered second\u2010line therapy is obeticholic acid (OCA) for UDCA\u2010inadequate responders. Despite the recent advances in understanding PBC pathogenesis and developing new treatments, many grey areas remain. Six Italian experts selected the following topics as the most urgent to address in PBC management: <jats:italic>diagnosis and natural history of PBC<\/jats:italic>: as a portion of the subjects with isolated AMA, normal alkaline phosphatase (ALP) levels and no symptoms of liver disease could have PBC by histology, defining how to manage and follow this population is crucial; <jats:italic>role of liver biopsy<\/jats:italic>: recent evidence suggests that biopsy may provide relevant information for risk stratification and prediction of UDCA response, possibly facilitating personalized approaches; <jats:italic>risk stratification<\/jats:italic>: the tools for risk stratification are well established, but some issues (eg bile acid dosage in routine practice) remain controversial; and <jats:italic>therapy<\/jats:italic>: those in more advanced stages of development are nuclear receptor modulators and fibrates, but more data are needed to plan personalized strategies. In this manuscript, for each topic, current evidence, controversies and future perspectives are summarized with the possible implications for clinical practice.<\/jats:p>","DOI":"10.1111\/liv.14627","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T21:04:14Z","timestamp":1596661454000},"page":"2590-2601","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel"],"prefix":"10.1111","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3771-9644","authenticated-orcid":false,"given":"Domenico","family":"Alvaro","sequence":"first","affiliation":[{"name":"Department of Translational and Precision Medicine Sapienza University of Rome Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8570-2519","authenticated-orcid":false,"given":"Guido","family":"Carpino","sequence":"additional","affiliation":[{"name":"Division of Health Sciences Department of Movement, Human and Health Sciences University of Rome \"Foro Italico\" Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-9544","authenticated-orcid":false,"given":"Antonio","family":"Craxi","sequence":"additional","affiliation":[{"name":"Gastroenterology and Liver Unit, PROMISE University of Palermo Palermo Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarosa","family":"Floreani","sequence":"additional","affiliation":[{"name":"Studioso Senior University of Padova and Scientific Consultant IRCCS Negrar Verona Italy"},{"name":"Scientific Consultant IRCCS Negrar Verona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[{"name":"Department of Interdisciplinary Medicine University of Bari \"Aldo Moro\" Bari Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3262-1998","authenticated-orcid":false,"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Center for Autoimmune Liver Diseases Department of Medicine and Surgery University of Milano\u2010Bicocca Monza Italy"},{"name":"European Reference Network on Hepatological Diseases (ERN RARE\u2010LIVER) San Gerardo Hospital Monza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.06.015"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.11.008"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1407"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105303242204"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405123301903"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.20240"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01235.x"},{"key":"e_1_2_14_10_1","first-page":"CD000551","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"12","author":"Rudic JS","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(18)30233-2"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.12.033"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1391093"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.05.023"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2018.03.006"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.02.013"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.10.004"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-916321"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979469"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02366.x"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29717"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270303"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)04410-8"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28859"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840060609"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.01.005"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2010.009282"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30163-8"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/003591576706001205"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432479"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2009.02500.x"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.09.017"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28326"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19102917"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.11.010"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.188367"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.11.034"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12100"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15533"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15583"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109680"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.08.013"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.005"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.029"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28017"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000290"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25599"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.030"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315259"},{"key":"e_1_2_14_50_1","article-title":"The challenges of primary biliary cholangitis: What is new and what needs to be done","volume":"102328","author":"Terziroli Beretta\u2010Piccoli B","year":"2019","journal-title":"J Autoimmun"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(03)00135-1"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1170"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28359"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70351-3"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20646"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(18)30293-9"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50266"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00135a001"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)00050-2"},{"key":"e_1_2_14_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27274"},{"key":"e_1_2_14_61_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210077"},{"key":"e_1_2_14_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27744"},{"key":"e_1_2_14_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10059-012-2297-y"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm990554g"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202464109"},{"key":"e_1_2_14_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00795-013-0017-0"},{"key":"e_1_2_14_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-019-00455-3"},{"key":"e_1_2_14_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.212159"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509840"},{"key":"e_1_2_14_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30094-9"},{"key":"e_1_2_14_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2019.12.114"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.11.069"},{"key":"e_1_2_14_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28932"},{"key":"e_1_2_14_74_1","first-page":"184","article-title":"The UK\u2010PBC audit of real\u2010world obeticholic acid use in patients with primary biliary cholangitis (PBC)","volume":"68","author":"Trivedi P","year":"2018","journal-title":"Hepatology"},{"key":"e_1_2_14_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2019.12.120"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0618-8278(19)30806-0"},{"key":"e_1_2_14_77_1","first-page":"188","article-title":"Obeticholic acid and bezafibrate in primary biliary cholangitis: A comparative evaluation of efficacy through real world clinical practice","volume":"70","author":"Culver E","year":"2019","journal-title":"Hepatology"},{"key":"e_1_2_14_78_1","first-page":"188","article-title":"Efficacy of obeticholic acid in primary biliary cholangitis\u2010autoimmune hepatitis overlap patients with persistently elevated transaminases despite immunosuppression","volume":"70","author":"Gerussi A","year":"2019","journal-title":"Hepatology"},{"key":"e_1_2_14_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0618-8278(19)30793-5"},{"key":"e_1_2_14_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(99)00033-9"},{"key":"e_1_2_14_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01667.x"},{"key":"e_1_2_14_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03220.x"},{"key":"e_1_2_14_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05413.x"},{"key":"e_1_2_14_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05944.x"},{"key":"e_1_2_14_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1778-1"},{"key":"e_1_2_14_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00305.x"},{"key":"e_1_2_14_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2015.02.011"},{"key":"e_1_2_14_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12373"},{"key":"e_1_2_14_89_1","first-page":"2757","article-title":"Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: A meta\u2010analysis","volume":"9","author":"Zhang Y","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"e_1_2_14_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714519"},{"key":"e_1_2_14_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.287"},{"key":"e_1_2_14_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30552"},{"key":"e_1_2_14_93_1","unstructured":"Fenofibrate FDA.pdf.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2004\/021656s000_Tricor_PrntLbl.pdf. Accessed November 26 2019."},{"key":"e_1_2_14_94_1","unstructured":"pravafenix\u2010epar\u2010product\u2010information_en.pdf.https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/pravafenix-epar-product-information_en.pdf. Accessed February 26 2020."},{"key":"e_1_2_14_95_1","unstructured":"Bezafibrato RCP.https:\/\/farmaci.agenziafarmaco.gov.it\/aifa\/servlet\/PdfDownloadServlet?pdfFileName=footer_003199_035414_FI.pdf&retry=0&sys=m0b1l3. Accessed November 26 2019."},{"key":"e_1_2_14_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0618-8278(19)30226-9"},{"key":"e_1_2_14_97_1","unstructured":"Releases Press.https:\/\/ir.cymabay.com\/press-releases\/detail\/476\/cymabay-therapeutics-halts-clinical-development-of-seladelpar. Accessed December 3 2019."},{"key":"e_1_2_14_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1173"},{"key":"e_1_2_14_99_1","unstructured":"A 5\u2010year longitudinal observational study of patients with primary biliary cholangitis \u2010 Full Text View\u2010 ClinicalTrials.gov.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02932449. Accessed November 11 2019."},{"key":"e_1_2_14_100_1","unstructured":"Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis\u2010 Full Text View \u2010 ClinicalTrials.gov.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02308111. Accessed November 11 2019."},{"key":"e_1_2_14_101_1","doi-asserted-by":"crossref","unstructured":"SoretPA LamL CarratF et al.Additive beneficial effects of fibrates combined with obeticholic acid in the treatment of patients with primary biliary cholangitis and inadequate response to second\u2010line therapy. Poster LP6. Late\u2010Breaking Abstracts \u2010 Presented at the 70th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver MeetingTM2019.Hepatology. 2019;70:1477A\u20131501A.","DOI":"10.1002\/hep.31033"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.14627","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.14627","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/liv.14627","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.14627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T16:11:07Z","timestamp":1693671067000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.14627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/liv.14627"],"URL":"https:\/\/doi.org\/10.1111\/liv.14627","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]},"assertion":[{"value":"2020-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}